Biotinoyl tripeptide-1 NEW
Price | $23 |
Package | 1Box |
Min. Order: | 1Box |
Supply Ability: | 10000Box |
Update Time: | 2024-05-15 |
Product Details
Product Name: Biotinoyl tripeptide-1 | CAS No.: 299157-54-3 |
Min. Order: 1Box | Purity: 99% |
Supply Ability: 10000Box | Release date: 2024/05/15 |
Chinese name: biotin tripeptide-1
English name: biotin tripeptide-1
CAS No. : 299157-54-3
Subtype: C24H38N8O6S
Subsize: 566.67
Precise molecular weight: 566.26400
PSA: 259.69000
Company Profile Introduction
Shanghai Getian Industrial Co.,Ltd is a leading enterprise committed to providing quality products and efficient logistics services. We are proud to introduce a range of products with excellent quality, and the industrial materials are subject to strict quality control to ensure that the high standards of our customers are met.
We have pharmaceutical raw material production factory and reagent research and development center. We now have a complete product line. In addition, we have developed and produced tens of thousands of reagents. We are complemented by a custom synthesis business of various organic compounds. We can synthesize almost any chemical.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$11.00/1KG |
VIP4Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-21 | |
$0.00/1G |
VIP1Y
|
Watson Biotechnology Co.,Ltd
|
2024-07-26 | |
$0.10/1KG |
VIP5Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2024-07-19 | |
$0.00/1kg |
VIP2Y
|
Wuhan Haorong Biotechnology Co.,Ltd
|
2024-07-09 | |
$120.00/1kg |
VIP1Y
|
Hebei Zhuanglai Chemical Trading Co.,Ltd
|
2024-05-22 | |
$0.00/1kg |
VIP1Y
|
Shanghai Affida new material science and technology center
|
2024-05-06 | |
$10.00/15mg |
VIP4Y
|
Shanghai UCHEM Inc.
|
2024-04-18 | |
$0.00/1g |
VIP1Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2024-04-18 | |
$30.00/1box |
VIP1Y
|
hebei hongtan Biotechnology Co., Ltd
|
2024-03-20 | |
$30.00/1Box |
VIP1Y
|
zhuzhou dingcheng meihei comestic co.,ltd
|
2023-12-07 |
- Since: 2024-01-19
- Address: Hong Kong
INQUIRY